Cargando…
The Efficacy, Safety, And Cost Savings Of High Dose IV Diuretics For Heart Failure Patients In An Outpatient Setting With Limited Hospital Bed Space Due To Covid-19
INTRODUCTION: Hospitalization is the greatest expenditure for heart failure treatment, estimated to be 8-15 billion dollars annually with the most common cost due to acute decompensation. An approach to manage this is an infusion clinic for outpatient diuresis and observation is an effective way to...
Autores principales: | Lau, Sirimas, Lau, Kyle R, Rathman, Lisa, Roberts, Justin D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090092/ http://dx.doi.org/10.1016/j.cardfail.2022.10.302 |
Ejemplares similares
-
Intérêt pronostique à cours et à long terme du scanner thoracique chez les patients atteints de COVID-19
por: El Wadhane, I., et al.
Publicado: (2022) -
COMPARAÇÃO DO PERFIL MICROBIOLÓGICO DE INFECÇÃO DE CORRENTE SANGUÍNEA ASSOCIADA A CATETER VASCULAR CENTRAL ANTES E DEPOIS DE SE INSTALAR A PANDEMIA DE COVID‐19
por: Rodrigues, Monica Peduto P., et al.
Publicado: (2021) -
A Practical Way to Reduce Healthcare Costs in Patients With Heart Failure: Outpatient IV Diuretics Therapy
por: Jung, Mi-Hyang
Publicado: (2022) -
Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study
por: Bianco, Claudia, et al.
Publicado: (2014) -
Impact of Outpatient Diuretic Infusion Therapy on Healthcare Cost and Readmissions
por: Nair, Nandini, et al.
Publicado: (2022)